BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹288 Cr | ₹236 Cr | ₹174 Cr | ₹141 Cr | ₹91 Cr |
What is the latest Total Expenditure of BETA DRUGS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹174 Cr |
| Mar2022 | ₹141 Cr |
| Mar2021 | ₹91 Cr |
How is Total Expenditure of BETA DRUGS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | 22.08 | |
| Mar2024 | ₹236 Cr | 35.48 | |
| Mar2023 | ₹174 Cr | 23.27 | |
| Mar2022 | ₹141 Cr | 54.46 | |
| Mar2021 | ₹91 Cr | - | |
Compare Total Expenditure of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,425.4 Cr | 1% | 53.5% | 22.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1% |
53.5% |
22.4% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses